ORCID
Thabo Hamiwe: https://orcid.org/0000-0002-1792-7975
Debbie White: https://orcid.org/0000-0002-0943-5970
Stanford Kwenda: https://orcid.org/0000-0002-9008-4898
Arshad Ismail: https://orcid.org/0000-0003-4672-5915
Marleen M. Kock: https://orcid.org/0000-0002-1768-9268
Anthony Smith: https://orcid.org/0000-0002-3637-7155
Marthie M. Ehlers: https://orcid.org/0000-0003-2199-6970
REFERENCES
1. Van Stormbroek B, Zampoli M, Morrow BM. Nebulized gentamicin in combination with systemic antibiotics for eradicating earlyPseudomonas aeruginosa infection in children with cystic fibrosis. Pediatr Pulmonol. 2019; 54:393-398.
2. Zampoli M, Verstraete J, Frauendorf M, Kassanjee R, Workman L, Morrow BM, Zar HJ. Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome. ERJ Open Res . 2021; 7:00856-2020.
3. da Silva LVRF, Zampoli M, Cohen-Cymberknoh M, Kabra SK. Cystic fibrosis in low and middle-income countries (LMIC): A view from four different regions of the world. Paediatr Respir Rev . 2021; 38:37-44.
4. Vandenbroucke NJ, Zampoli M, Morrow B. Lung function determinants and mortality of children and adolescents with cystic fibrosis in South Africa 2007‐2016. Pediatr Pulmonol. 2020; 55:1381-1387.
5. Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains ofPseudomonas aeruginosa in cystic fibrosis lung infections.Eur Respir J . 2012; 40: 227-238.
6. Zampoli M and Morrow B. The South African Cystic Fibrosis Consensus/Guidelines 5thEdition.2017.https://www.sacfa.org.za/wpcontent/uploads/20170914CFConsensusGuidelines2017.pdf. Accessed August 8, 2023
7. Duong J, Booth SC, McCartney NK, Rabin HR, Parkins MD, Storey DG. Phenotypic and genotypic comparison of epidemic and non-epidemic strains of Pseudomonas aeruginosa from individuals with cystic fibrosis.PLoS One . 2015; 10: e0143466.
8. Schmid J, Ling LJ, Leung JL, Zhang N, Kolbe J, Wesley AW, Mills GD, Brown PJ, Jone DT, Laing RTR, et al. Pseudomonas aeruginosatransmission is infrequent in New Zealand cystic fibrosis clinics.Eur Respir J . 2008; 32:1583-1590.
9. Workentine M, Poonja A, Waddell B, Duong J, Storey DG, Gregson D, Somayaji R, Rabin HR, Surette MG, Parkins MD. Development and validation of a PCR assay to detect the prairie epidemic strain ofPseudomonas aeruginosa from patients with cystic fibrosis.J Clin Microbiol . 2016; 54:489-491.
10. Wee BA, Tai AS, Sherrard LJ, Ben Zakour NL, Hanks KR, Kidd TJ, Ramsay KA, Lamont I, Whiley DM, Bell SC et al. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre. BMC Genom . 2018; 19:644.
11. Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A, Paterson N, Jackson M, Lougheed MD, Dowson C et al. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. Jama . 2010; 304:2145-2153.
12. Parkins MD, Somayaji R, Waters VJ. Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis.Clin Microbiol Rev . 2018; 31: e00019-18.
13. Acosta N, Waddell B, Heirali A, Somayaji R, Surette MG, Workentine ML, Rabin HR, Parkins MD. Cystic fibrosis patients infected with epidemic Pseudomonas aeruginosa strains have unique microbial communities. Front Cell Infect Microbiol . 2020; 10:173.
14. Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW et al. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres.Eur Respir J . 2013; 41:1091-1100.
15. Bradbury RS, Champion AC, Reid DW. Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital. J Hosp Infect . 2009; 73:151-156.
16. Douraghi M, Ghasemi F, Dallal MS, Rahbar M, Rahimiforoushani A. Molecular identification of Pseudomonas aeruginosa recovered from cystic fibrosis patients. J Pre Med Hyg . 2014; 55: 50-53.
17. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 31st Edition. CLSI Supplement M100. Clinical and Laboratory Standards Institute, USA, 2021.
18. Botelho J, Grosso F, Peixe L. Antibiotic resistance inPseudomonas aeruginosa -mechanisms, epidemiology and evolution.Drug Resist Updat . 2019; 44: 26-47.
19. De Oliveira Santos IC, de Andrade NFP, da Conceição Neto OC, da Costa BS, de Andrade Marques E, Rocha-de-Souza CM, Asensia MD, D’Alincourt Carvalho-Assef AP. Epidemiology and antibiotic resistance trends in clinical isolates of Pseudomonas aeruginosa from Rio de Janeiro-Brazil: Importance of mutational mechanisms over the years (1995–2015). Infect Genet Evol . 2019; 73: 411-415.
20. Kwenda S, Khumalo ZTH, Mtshali S, Mnyameni F, Ismail A. Jekesa: an automated easy-to-use pipeline for bacterial whole genome typing. 2020 https://github.com/stanikae/jekesa.
21. Smith AM, Erasmus LK, Tau NP, Smouse SL, Ngomane HM, Disenyeng B, Whitelaw A, Lawrence CA, Sekwadi P, Thomas J. Enteric fever cluster identification in South Africa using genomic surveillance ofSalmonella enterica serovar Typhi. Microb. Genom . 2023; 9: 001044.
22. Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR, Wlodarski MA, Edalatmand A, Petkau A, Syed SA, Tsang KK et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res . 2023; 51: D690-D699.
23. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, Philippon A, Allesoe RL, Rebelo AR, Florensa AF et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J. Antimicrob. Chemother . 2020; 12: 3491-500.
24. Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, Connor R, Funk K, Kelly C, Kim S et al. Database resources of the national center for biotechnology information. Nucleic Acids Res . 2022; 50: D20-D26.
25. Seemann T. Whole genome core alignments from multiple draft genomes. 2016. https://github.com/tseemann/scapper
26. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins.Nucleic Acids Res . 2014; 43: e15
27. Page AJ, Taylor B, Delaney AJ, Soares J, Seemann T, Keane JA, Harris SR. SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments. Microb. Genom . 2016; 2: e000056
28. Kassambara A, Mundt F. Factoextra: extract and visualize the results of multivariate data analyses. R Package Version 1.0.7. 2020 https://CRAN.R-project.org/package=factoextra
29. Gu Z. Complex heatmap visualization. Imeta . 2022; 1:e43.
30. Bradbury R, Champion A, Reid DW. Poor clinical outcomes associated with a multi‐drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.Respirol . 2008; 13:886-892.
31. Aeschlimann JR. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gram‐negative bacteria: insights from the Society of Infectious Diseases Pharmacists.Pharmacother . 2003; 23:916-924.
32. Zahedi Bialvaei A, Rahbar M, Hamidi-Farahani R, Asgari A, Esmailkhani A, Mardani Dashti Y, Soleiman-Meigooni S. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains. Microb Pathog . 2021; 153:104789.
33. Barnes MD, Bethel CR, Alsop J, Becka SA, Rutter JD, Papp-Wallace KM, Bonomo RA. Inactivation of the Pseudomonas -derived cephalosporinase-3 (PDC-3) by relebactam. Antimicrob Agents Chemother . 2018; 62: e02406-17.
34. Rehman A, Patrick WM, Lamont IL. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa : new approaches to an old problem. J Med Microbiol . 2019; 68:1-10.
35. Ortiz de la Rosa JMO, Nordmann P, Poirel L. Pathogenicity genomic island-associated CrpP-Like fluoroquinolone-modifying enzymes amongPseudomonas aeruginosa clinical isolates in Europe.Antimicrob Agents Chemother . 2020; 64: e00489-20.
36. Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and alternative therapeutic strategies. Biotechnol Adv . 2019; 37: 177-192.
37. Aghapour A, Gholizadeh P, Ganbarov K, Bialvaei AZ, Mahmood SS, Tanomand A, Yousefi M, Asgharzadeh M, Yousefi B, Kafil HS. Molecular mechanisms related to colistin resistance in Enterobacteriaceae .Infect Drug Resist. 2019; 965-975.
38. Crush J, Chikanda A, Pendleton WC, Caesar MS, Ramachandran S, Eberhardt CP, Hill A. Divided Diasporas: Southern Africans in Canada: Special Report. Centre for International Governance Innovation; 2013. I-100